Thursday, July 9, 2020

$BCRX

According to analysts' consensus price target of $8.33, BioCryst Pharmaceuticals has a potential upside of 53.5% from its current price of $5.43.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)